Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Chlamydia Infections/*diagnosis ; Chlamydia trachomatis/*genetics ; Gonorrhea/*diagnosis ; Neisseria gonorrhoeae/*genetics ; Real-Time Polymerase Chain Reaction/*methods; Adult ; Chlamydia Infections/urine ; Chlamydia trachomatis/isolation & purification ; Genitalia/microbiology ; Gonorrhea/urine ; Homosexuality, Male ; Humans ; Male ; Neisseria gonorrhoeae/isolation & purification ; Nucleic Acid Amplification Techniques/methods ; Sensitivity and Specificity

Background: Extra-genital Neisseria gonorrhoeae and Chlamydia trachomatis infections are mostly asymptomatic, and important reservoir sites of infection as they often go undetected and may be more difficult to eradicate with recommended therapeutic regimens. Commercial nucleic acid amplification tests (NAATs) have not received regulatory approval for the detection of N. gonorrhoeae and C. trachomatis in extra-genital specimens. The HOLOGIC® APTIMA Combo2 assay for N. gonorrhoeae and C. trachomatis has performed well in evaluations using extra-genital specimens.
Methods: We assessed the performance of an in-house real-time duplex PCR assay for the detection of N. gonorrhoeae and C. trachomatis in urine and extra-genital specimens using the HOLOGIC® APTIMA assays as gold standard comparators. Urine, oropharyngeal and ano-rectal specimens were collected from each of 200 men-who-have-sex-with-men (MSM) between December 2011 and July 2012.
Results: For N. gonorrhoeae detection, the in-house PCR assay showed 98.5-100% correlation agreement with the APTIMA assays, depending on specimen type. Sensitivity for N. gonorrhoeae detection was 82.4% for ano-rectal specimens, 83.3% for oropharyngeal specimens, and 85.7% for urine; and specificity was 100% with all specimen types. The positive predictive value (PPV) for N. gonorrhoeae detection was 100% and the negative predictive value (NPV) varied with sample type, ranging from 98.5-99.5%. For C. trachomatis detection, correlation between the assays was 100% for all specimen types. The sensitivity, specificity, PPV and NPV of the in-house PCR assay was 100% for C. trachomatis detection, irrespective of specimen type.
Conclusion: The in-house duplex real-time PCR assay showed acceptable performance characteristics in comparison with the APTIMA® assays for the detection of extra-genital N. gonorrhoeae and C. trachomatis.

Sex Transm Dis. 2010 Sep;37(9):566-70. (PMID: 20502394)
Clin Infect Dis. 2005 Jul 1;41(1):67-74. (PMID: 15937765)
Int J STD AIDS. 2007 Dec;18(12):871-2. (PMID: 18073027)
Clin Infect Dis. 2009 May 1;48(9):1237-43. (PMID: 19323630)
Sex Transm Infect. 2002 Jun;78(3):190-3. (PMID: 12238651)
MMWR Recomm Rep. 2014 Mar 14;63(RR-02):1-19. (PMID: 24622331)
Sex Transm Infect. 2006 Dec;82(6):515. (PMID: 17151040)
Sex Health. 2011 Mar;8(1):9-11. (PMID: 21371376)
MMWR Morb Mortal Wkly Rep. 2009 Jul 10;58(26):716-9. (PMID: 19590491)
Clin Infect Dis. 2014 Jun;58(11):1564-70. (PMID: 24647015)
J Clin Microbiol. 2012 Jun;50(6):2005-8. (PMID: 22493338)
J Clin Microbiol. 2010 May;48(5):1827-32. (PMID: 20335410)
Sex Transm Dis. 2008 Jul;35(7):637-42. (PMID: 18520976)
Expert Opin Pharmacother. 2009 Mar;10(4):555-77. (PMID: 19284360)
J Clin Microbiol. 2004 Jul;42(7):3089-93. (PMID: 15243065)
BMC Infect Dis. 2011 Jul 26;11:203. (PMID: 21791061)
Sex Transm Dis. 2016 Feb;43(2):105-9. (PMID: 26766527)
Clin Infect Dis. 2006 Nov 15;43(10):1284-9. (PMID: 17051493)
J Clin Microbiol. 2009 Apr;47(4):902-7. (PMID: 19193848)
J Clin Microbiol. 2003 Jan;41(1):304-9. (PMID: 12517865)
Can J Infect Dis Med Microbiol. 2005 Jan;16(1):39-44. (PMID: 18159527)
J Clin Microbiol. 2009 Jun;47(6):1657-62. (PMID: 19369445)
PLoS One. 2015 Sep 29;10(9):e0138315. (PMID: 26418464)
Euro Surveill. 2014 Jul 31;19(30):. (PMID: 25108533)
Sex Transm Infect. 2009 Jun;85(3):182-6. (PMID: 19126571)
Clin Microbiol Rev. 2014 Jul;27(3):587-613. (PMID: 24982323)
Int J STD AIDS. 2009 May;20(5):315-9. (PMID: 19386967)
Antimicrob Agents Chemother. 2011 Jul;55(7):3538-45. (PMID: 21576437)
BMC Public Health. 2013 Nov 25;13:1093. (PMID: 24274101)
Sex Transm Infect. 2009 Jun;85(3):159-60. (PMID: 19478103)
Sex Transm Dis. 2012 Jul;39(7):543-9. (PMID: 22706217)
J Clin Microbiol. 2011 May;49(5):1970-1. (PMID: 21411585)
Sex Transm Dis. 2010 Dec;37(12):771-6. (PMID: 20585275)

AID-674-A-12-00015 United States Agency for International Development

Keywords: APTIMA; Chlamydia trachomatis; Extra-genital; In-house real-time PCR; Neisseria gonorrhoeae; Urine

Date Created: 20190105 Date Completed: 20190211 Latest Revision: 20240516

20240516

PMC6318993

10.1186/s12879-018-3629-0

30606127